HomeIngredientSilica Nanoparticles Enhance the Disease Resistance of Ginger to Rhizome Rot during Postharvest Storage

Silica Nanoparticles Enhance the Disease Resistance of Ginger to Rhizome Rot during Postharvest Storage

August 20, 2022

Nanomaterials (Basel). 2022 Apr 21;12(9):1418. doi: 10.3390/nano12091418.

ABSTRACT

Silica nanoparticles (SiNPs) offer an ecofriendly and environmentally safe alternative for plant disease management. However, the mechanisms of SiNPs-induced disease resistance are largely unknown. This research evaluated the application of SiNPs in controlling the postharvest decay of ginger rhizomes inoculated with Fusarium solani. In vitro study showed that SiNP had little inhibitory effect on mycelial growth and spore germination of F. solani and did not significantly change mycelium’s MDA content and SDH activity. In vivo analysis indicated that SiNPs decreased the degree of decay around the wounds and decreased the accumulation of H2O2 after long-term pathogenic infection through potentiating the activities of antioxidant enzymes such as SOD, APX, PPO, and CAT. SiNP150 increased the CHI, PAL, and GLU activity at the onset of the experiment. Moreover, SiNP150 treatment increased total phenolics contents by 1.3, 1.5, and 1.2-times after 3, 5, and 7 days of treatment, and increased total flavonoids content throughout the experiment by 9.3%, 62.4%, 26.9%, 12.8%, and 60.8%, respectively. Furthermore, the expression of selected phenylpropanoid pathway-related genes was generally enhanced by SiNPs when subjected to F. solani inoculation. Together, SiNPs can effectively reduce the fungal disease of ginger rhizome through both physical and biochemical defense mechanisms.

PMID:35564127 | DOI:10.3390/nano12091418

Tags:

Related Posts

About The Author

Patrick Blanchard MD

Meet Dr. Blanchard Dr. Blanchard’s medical practice is an embodiment of Integrative health which brings conventional and complementary approaches together in a coordinated way. Conveniently located in sunny Florida and over the internet with ValiseMD’s secure HIPPA compliant telXmed servers. Since 1994, patients with a wide range of challenging medical problems have achieved optimum health using the best of natural medicine, judiciously combined with high-tech innovations. Breakthroughs are often achieved even after patients have consulted mainstream specialists and holistic practitioners. Dr. Blanchard is founder and CEO of ValiseMD, Inc. He is board certified in Family Medicine since 1994 and awarded Fellow of the American Academy of Family Physicians in 2001. He received the ‘Teacher of the Year’ award from the University of Kansas School of Medicine at completion of his residency in Family Medicine. He completed a fellowship at Wake Forest University in the field of vascular neurosonology. He holds a medical patent in the field of Gastroenterology. He holds an unrestricted license to practice medicine and surgery in Florida. He started his medical career as a Emergency Medical Technician, then as a Paramedic and later a Medical Doctor.